17 April 2020, USD/JPY
USDJPY trading plan:
Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week. The University of Chicago Medicine recruited 125 people with Covid-19 into Gilead’s two Phase 3 clinical trials. Of those people, 113 had severe disease. All the patients have been treated with daily infusions of remdesivir. This is a good signal for the stock market and USD JPY, which has a correlation with the shares.
Trading recommendation: Buy 107.55 and take profit 107.90.